Cargando…

Standardized image quality for (68)Ga-DOTA-TATE PET/CT

BACKGROUND: Positron emission tomography (PET) imaging with (68)Gallium labeled somatostatin analogues ((68)Ga-DOTA-SSA) plays a key role in neuroendocrine tumor management. The impact of patient size on PET image quality is not well known for PET imaging with (68)Ga-DOTA-SSA. The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Christina P. W., Segbers, Marcel, Graven, Laura H., Brabander, Tessa, van Assema, Daniëlle M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085989/
https://www.ncbi.nlm.nih.gov/pubmed/32201912
http://dx.doi.org/10.1186/s13550-020-0601-y
_version_ 1783509045945040896
author Cox, Christina P. W.
Segbers, Marcel
Graven, Laura H.
Brabander, Tessa
van Assema, Daniëlle M. E.
author_facet Cox, Christina P. W.
Segbers, Marcel
Graven, Laura H.
Brabander, Tessa
van Assema, Daniëlle M. E.
author_sort Cox, Christina P. W.
collection PubMed
description BACKGROUND: Positron emission tomography (PET) imaging with (68)Gallium labeled somatostatin analogues ((68)Ga-DOTA-SSA) plays a key role in neuroendocrine tumor management. The impact of patient size on PET image quality is not well known for PET imaging with (68)Ga-DOTA-SSA. The aim of this study is to propose a dose regimen based on patient size that optimizes image quality and yields sufficient image quality for diagnosis. METHODS: Twenty-one patients (12 males, 9 females) were prospectively included for (68)Gallium-DOTA-Tyr3-Octreotate ((68)Ga-DOTA-TATE) PET/CT, which was acquired in whole body list mode using 6 min per bed position (mbp). The list-mode events were randomly sampled to obtain 1 to 6 mbp PET reconstructions. For semi-quantitative assessment of image quality, the signal-to-noise ratio (SNR) was measured in the liver. The SNR normalized (SNRnorm) for administered activity and mbp was correlated with body mass, length, body mass index, body mass/length, and lean body mass. Three experienced nuclear medicine physicians visually graded image quality using a 4-point scale, and categorically scored the number of somatostatin-receptor positive lesions for each reconstruction. To investigate the impact of image quality on lesion quantification, the mean, maximum, and peak standardized uptake values (SUVs) of one abdominal lesion were measured in the 1 to 6 mbp PET reconstructions. RESULTS: Of all patient-dependent parameters, body mass showed the strongest correlation (R(2) = 0.6) with SNRnorm. Lesion detectability analysis showed no significant difference for 3-5 mbp compared with the complete 6 mbp PET reconstruction. The SUV measurements showed no significant (p > 0.05) differences across the reconstructions. Visual assessment revealed that an SNR of 6.2 results in PET scans with moderate to good image quality. A non-linear expression was derived to calculate the required (dose × acquisition time) product (DTP) for the chosen SNR level of 6.2 that would yield a more constant image quality. CONCLUSION: Body mass can be used to predict (68)Ga-DOTA-TATE PET image quality. The proposed non-linear dose regimen based on body mass standardizes the image quality while maintaining sufficient image quality for diagnosis.
format Online
Article
Text
id pubmed-7085989
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-70859892020-03-23 Standardized image quality for (68)Ga-DOTA-TATE PET/CT Cox, Christina P. W. Segbers, Marcel Graven, Laura H. Brabander, Tessa van Assema, Daniëlle M. E. EJNMMI Res Original Research BACKGROUND: Positron emission tomography (PET) imaging with (68)Gallium labeled somatostatin analogues ((68)Ga-DOTA-SSA) plays a key role in neuroendocrine tumor management. The impact of patient size on PET image quality is not well known for PET imaging with (68)Ga-DOTA-SSA. The aim of this study is to propose a dose regimen based on patient size that optimizes image quality and yields sufficient image quality for diagnosis. METHODS: Twenty-one patients (12 males, 9 females) were prospectively included for (68)Gallium-DOTA-Tyr3-Octreotate ((68)Ga-DOTA-TATE) PET/CT, which was acquired in whole body list mode using 6 min per bed position (mbp). The list-mode events were randomly sampled to obtain 1 to 6 mbp PET reconstructions. For semi-quantitative assessment of image quality, the signal-to-noise ratio (SNR) was measured in the liver. The SNR normalized (SNRnorm) for administered activity and mbp was correlated with body mass, length, body mass index, body mass/length, and lean body mass. Three experienced nuclear medicine physicians visually graded image quality using a 4-point scale, and categorically scored the number of somatostatin-receptor positive lesions for each reconstruction. To investigate the impact of image quality on lesion quantification, the mean, maximum, and peak standardized uptake values (SUVs) of one abdominal lesion were measured in the 1 to 6 mbp PET reconstructions. RESULTS: Of all patient-dependent parameters, body mass showed the strongest correlation (R(2) = 0.6) with SNRnorm. Lesion detectability analysis showed no significant difference for 3-5 mbp compared with the complete 6 mbp PET reconstruction. The SUV measurements showed no significant (p > 0.05) differences across the reconstructions. Visual assessment revealed that an SNR of 6.2 results in PET scans with moderate to good image quality. A non-linear expression was derived to calculate the required (dose × acquisition time) product (DTP) for the chosen SNR level of 6.2 that would yield a more constant image quality. CONCLUSION: Body mass can be used to predict (68)Ga-DOTA-TATE PET image quality. The proposed non-linear dose regimen based on body mass standardizes the image quality while maintaining sufficient image quality for diagnosis. Springer Berlin Heidelberg 2020-03-23 /pmc/articles/PMC7085989/ /pubmed/32201912 http://dx.doi.org/10.1186/s13550-020-0601-y Text en © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Cox, Christina P. W.
Segbers, Marcel
Graven, Laura H.
Brabander, Tessa
van Assema, Daniëlle M. E.
Standardized image quality for (68)Ga-DOTA-TATE PET/CT
title Standardized image quality for (68)Ga-DOTA-TATE PET/CT
title_full Standardized image quality for (68)Ga-DOTA-TATE PET/CT
title_fullStr Standardized image quality for (68)Ga-DOTA-TATE PET/CT
title_full_unstemmed Standardized image quality for (68)Ga-DOTA-TATE PET/CT
title_short Standardized image quality for (68)Ga-DOTA-TATE PET/CT
title_sort standardized image quality for (68)ga-dota-tate pet/ct
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085989/
https://www.ncbi.nlm.nih.gov/pubmed/32201912
http://dx.doi.org/10.1186/s13550-020-0601-y
work_keys_str_mv AT coxchristinapw standardizedimagequalityfor68gadotatatepetct
AT segbersmarcel standardizedimagequalityfor68gadotatatepetct
AT gravenlaurah standardizedimagequalityfor68gadotatatepetct
AT brabandertessa standardizedimagequalityfor68gadotatatepetct
AT vanassemadanielleme standardizedimagequalityfor68gadotatatepetct